SNRPG
Small nuclear ribonucleoprotein G
Also known as: RUXG_HUMAN, Sm-G
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62308
- Gene
- SNRPG
- Ensembl
- ENSG00000143977
- Chromosome
- 2
- Canonical length
- 76 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a component of the U1, U2, U4, and U5 small nuclear ribonucleoprotein complexes, precursors of the spliceosome. The encoded protein may also be a part of the U7 small nuclear ribonucleoprotein complex, which participates in the processing of the 3' end of histone transcripts. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
Canonical amino-acid sequenceUniProt
76 residues, UniProt reviewed canonical sequence.
>P62308|SNRPG
1 MSKAHPPELK KFMDKKLSLK LNGGRHVQGI LRGFDPFMNL VIDECVEMAT SGQQNNIGMV
61 VIRGNSIIML EALERVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SNRPG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 130 nTPM
Expression across tissuesHPA
Tissue
- thymus: 130 nTPM
- choroid plexus: 117 nTPM
- bone marrow: 111 nTPM
- heart muscle: 100 nTPM
- epididymis: 97 nTPM
- lymph node: 94 nTPM
Single-cell type
- extravillous trophoblasts: 802 nCPM
- migrating cytotrophoblasts: 786 nCPM
- cytotrophoblasts: 670 nCPM
- esophageal basal cells: 564 nCPM
- gastric progenitor cells: 522 nCPM
- syncytiotrophoblasts: 461 nCPM
Immune cell
- plasmacytoid DC: 274 nTPM
- total PBMC: 265 nTPM
- T-reg: 231 nTPM
- non-classical monocyte: 224 nTPM
- intermediate monocyte: 220 nTPM
- memory B-cell: 210 nTPM
Brain region
- white matter: 42 nTPM
- choroid plexus: 37 nTPM
- medulla oblongata: 35 nTPM
- spinal cord: 35 nTPM
- thalamus: 35 nTPM
- hypothalamus: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 1.54
- DepMap mean gene effect
- -2.06
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 7-methylguanosine cap hypermethylation
- mRNA splicing, via spliceosome
- RNA splicing
- spliceosomal complex assembly
- spliceosomal snRNP assembly
- U2-type prespliceosome assembly
Molecular functions
Cellular components
- catalytic step 2 spliceosome
- cytosol
- methylosome
- nucleoplasm
- nucleus
- P granule
- precatalytic spliceosome
- small nuclear ribonucleoprotein complex
- SMN-Sm protein complex
- spliceosomal complex
- spliceosomal tri-snRNP complex
- U1 snRNP
- U12-type spliceosomal complex
- U2 snRNP
- U2-type catalytic step 2 spliceosome
- U2-type precatalytic spliceosome
- U2-type prespliceosome
- U2-type spliceosomal complex
- U4 snRNP
- U4/U6 x U5 tri-snRNP complex
- U5 snRNP
- U7 snRNP
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SNRPG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SNRPG as an antibody target. Whether an autoantibody or antibody against SNRPG could matter depends on whether native SNRPG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SNRPG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SNRPG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...